• 
• 
• 

FDA News and Drug Updates

FDA Approves Polivy in Combination with Bendamustine plus rituximab for Patients with Relapsed, Refractory DLBCL

Xpovio plus Dexamethasone Combination Receives Accelerated Approval for the Treatment of Patients with Relapsed or Refractory MM

FDA News

Keytruda Approved for Patients with Previously Treated Metastatic Small-Cell Lung Cancer

Side-Effects Management

NCCN Issues First Guideline for Immunotherapy-Related Adverse Events

Wayne Kuznar

Suboptimal Dosing of Filgrastim Is Acceptable for Treatment of Chemotherapy-Induced Neutropenia

Audrey Andrews

Understanding Immunotherapy Late Adverse Effects in Cancer Survivors

Meg Barbor, MPH

Immunotherapy Combination Shows Promising Results in HER2 1+/2+ Breast Cancer

The Challenges of Oral Cancer Drugs Use and Side-Effects Management

Meg Barbor, MPH

View All Side-Effects Management Articles

Immunotherapy

Overcoming Current Barriers to the Use of CAR T-Cell Therapy in the Community Setting

Chase Doyle

CAR T-Cell Therapy Targeting Solid Tumors

Chase Doyle

CAR T-Cell Therapy Fills Unmet Needs in Leukemia and Lymphoma

Wayne Kuznar

Genomic Markers of Response Improve Patient Selection for Immune Checkpoint Inhibitor Therapy

Wayne Kuznar

CAR T-Cell Therapy Associated with Unique, Acute Adverse Events Requiring Vigilant Monitoring

Wayne Kuznar

View All Immunotherapy Articles

Conference Correspondent

Sexual Dysfunction After Cancer: Why Aren’t We Talking About It?

The Importance of Compassion: Perspective From a Lifelong Patient

Using a Team Approach to Tackle Opioid Abuse in Patients with Cancer

Addressing the Second Victim Phenomenon

Palliative Care Use Dismal Among Patients with Hematologic Malignancies

Oral Multiple Myeloma Medication Linked to Decreased Productivity Loss

Ivosidenib, New IDH1 Inhibitor, Elicits Complete Response in Relapsed Acute Myeloid Leukemia

View All Conference Correspondent Articles

Most Popular Articles

FDA News

TOP - August 2019, Vol 12, No 3 - FDA Approvals

CAR T-Cell Therapy Targeting Solid Tumors

Chase Doyle

TOP - August 2019, Vol 12, No 3 - Immunotherapy

Keytruda Approved for Patients with Previously Treated Metastatic Small-Cell Lung Cancer

Yvette Florio Lane

Web Exclusives - FDA Approvals, In the News

FDA Unveils Pilot Program to Expand Access to Investigational Oncology Drugs

Phoebe Starr

TOP - August 2019, Vol 12, No 3 - ASCO

Enzalutamide or Apalutamide Added to ADT Are 2 New Options for Hormone-Sensitive Prostate Cancer

Phoebe Starr

TOP - August 2019, Vol 12, No 3 - Prostate Cancer